Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total Stockholder's Equity [Member]	Common Stock	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Treasury Stock [Member]	Deferred Compensation [Member]	Noncontrolling Interests [Member]	Series B Preferred Stock	Total
Beginning Balance at Oct. 31, 2021	$ 642,438	$ 37	$ 1,908,471	$ (1,265,251)	$ (819)	$ (586)	$ 586			$ 642,438
Beginning Balance at (in shares) at Oct. 31, 2021		366,618,693
Common stock issued, non-employee compensation	100		100							100
Common stock issued, non-employee compensation (in shares)		20,673
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards	(260)		(260)							(260)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)		60,052
Share based compensation	1,470		1,470							1,470
Preferred dividends - Series B	(800)		(800)						$ (800)	(800)
Effect of foreign currency translation	(91)				(91)					(91)
Adjustment for deferred compensation						(64)	64
Adjustment for deferred compensation (in shares)		(13,232)
Net loss attributable to redeemable noncontrolling interests	5,496			5,496				$ (5,496)
Net loss	(46,120)			(46,120)						(46,120)
Ending Balance at Jan. 31, 2022	602,233	$ 37	1,908,981	(1,305,875)	(910)	(650)	650	(5,496)		596,737
Ending Balance at (in shares) at Jan. 31, 2022		366,686,186
Beginning Balance at Oct. 31, 2021	642,438	$ 37	1,908,471	(1,265,251)	(819)	(586)	586			642,438
Beginning Balance at (in shares) at Oct. 31, 2021		366,618,693
Preferred dividends - Series B										(800)
Effect of foreign currency translation										(91)
Net loss attributable to noncontrolling interests										5,496
Net loss										(46,120)
Ending Balance at Oct. 31, 2022	684,392	$ 41	2,094,076	(1,407,973)	(1,752)	(855)	855	7,105		$ 691,497
Ending Balance at (in shares) at Oct. 31, 2022		405,562,988								405,562,988
Common stock issued, non-employee compensation	68		68							$ 68
Common stock issued, non-employee compensation (in shares)		21,106
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards	(314)		(314)							(314)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)		169,065
Share based compensation	2,637		2,637							2,637
Preferred dividends - Series B	(800)		(800)						$ (800)	(800)
Effect of foreign currency translation	447				447					447
Adjustment for deferred compensation						(68)	68
Adjustment for deferred compensation (in shares)		(21,106)
Reclass of redeemable non-controlling interest								3,030		3,030
Distribution to noncontrolling interest								(106)		(106)
Net loss attributable to noncontrolling interests	2,464			2,464				(2,464)		2,464
Net loss	(21,086)			(21,086)						(21,086)
Ending Balance at Jan. 31, 2023	$ 667,808	$ 41	$ 2,095,667	$ (1,426,595)	$ (1,305)	$ (923)	$ 923	$ 7,565		$ 675,373
Ending Balance at (in shares) at Jan. 31, 2023		405,732,053								405,732,053